Current Environment:

Summary

Investigate the inhibitor development rate of Human cl rhFVIII in previously untreated patients with severe Hemophilia A.

Conditions

Severe Hemophilia A

Recruitment Status

Completed

Eligibility Criteria

Inclusion Criteria:

Male patients
Severe Hemophilia A (FVIII:C <1%)
No previous treatment with FVIII concentrates or other blood products containing FVIII

Exclusion Criteria:

Diagnosis with a coagulation disorder other than Hemophilia A
Severe liver or kidney disease
Concomitant treatment with any systemic immunosuppressive drug

Intervention

Intervention Type

Intervention Name

Biological

Human cl rhFVIII

Phase

Phase 3

Gender

Male

Minimum Age

N/A

Maximum Age

N/A

Download Date

January 19, 2021

Principal Investigator

N/A

Primary Contact Information

For more information on this trial, visit clinicaltrials.gov.

Contact

For more information and to contact the study team: